secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001213900-25-125838
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma receives Nasdaq extension until June 22, 2026 to regain minimum bid price compliance
--------------------------------------------------------------------------------

- Company failed to meet $1.00 minimum bid price requirement by initial Dec. 24, 2025 deadline.
- Nasdaq granted a 180-day extension, new compliance deadline is June 22, 2026.
- Common stock continues trading on The Nasdaq Capital Market under symbol SILO.
- If bid price closes at or above $1.00 for 10 consecutive business days, compliance will be achieved.
- Company may consider a reverse stock split during second compliance period if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390025125838/0001213900-25-125838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390025125838/ea0271073-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-125838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer